Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Gradishar

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|May 27, 2008
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtableJulie Gralow, Hope Rugo, William Gradishar, et al.
Journal of Adolescent and Young Adult Oncology|August 12, 2016
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskSara Giordano, Elizabeth Garrett-Mayer, Navdha Mittal, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 21, 2009
Increased HER2/neu expression in recurrent hormone receptor-positive breast cancerVirginia G Kaklamani, Mary Cianfrocca, Jennifer Ciccone, et al.
Contemporary Clinical Trials Communications|January 6, 2022
Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancerPatricia I Moreno, Fiona S Horner, Joanna B Torzewski, et al.
Drugs|September 22, 2019
Are Biosimilars the Future of Oncology and Haematology?Pier Luigi Zinzani, Martin Dreyling, William Gradishar, et al.
Journal of Psychosocial Oncology Research and Practice|June 29, 2023
Characterizing unique supportive care needs among women living with metastatic breast cancer: A qualitative studyPatricia I Moreno, Blanca Noriega Esquives, Jessica L Thomas, et al.
Endocrinology|March 4, 2022
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic ManagementShelby Lynn Hophan, Olena Odnokoz, Huiping Liu, et al.
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Molecular Cancer Therapeutics|April 28, 2017
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast CancerYoung Kwang Chae, Andrew A Davis, Sarika Jain, et al.
JMIR Research Protocols|April 23, 2021
A Technology-Based Physical Activity Intervention for Patients With Metastatic Breast Cancer (Fit2ThriveMB): Protocol for a Randomized Controlled TrialSiobhan Phillips, Payton Solk, Whitney Welch, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|May 27, 2008
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtableJulie Gralow, Hope Rugo, William Gradishar, et al.
Journal of Adolescent and Young Adult Oncology|August 12, 2016
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskSara Giordano, Elizabeth Garrett-Mayer, Navdha Mittal, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 21, 2009
Increased HER2/neu expression in recurrent hormone receptor-positive breast cancerVirginia G Kaklamani, Mary Cianfrocca, Jennifer Ciccone, et al.
Contemporary Clinical Trials Communications|January 6, 2022
Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancerPatricia I Moreno, Fiona S Horner, Joanna B Torzewski, et al.
Drugs|September 22, 2019
Are Biosimilars the Future of Oncology and Haematology?Pier Luigi Zinzani, Martin Dreyling, William Gradishar, et al.
Journal of Psychosocial Oncology Research and Practice|June 29, 2023
Characterizing unique supportive care needs among women living with metastatic breast cancer: A qualitative studyPatricia I Moreno, Blanca Noriega Esquives, Jessica L Thomas, et al.
Endocrinology|March 4, 2022
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic ManagementShelby Lynn Hophan, Olena Odnokoz, Huiping Liu, et al.
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Molecular Cancer Therapeutics|April 28, 2017
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast CancerYoung Kwang Chae, Andrew A Davis, Sarika Jain, et al.
JMIR Research Protocols|April 23, 2021
A Technology-Based Physical Activity Intervention for Patients With Metastatic Breast Cancer (Fit2ThriveMB): Protocol for a Randomized Controlled TrialSiobhan Phillips, Payton Solk, Whitney Welch, et al.
Pageof 8